{ "schema_version": 1, "kind": "condition", "id": "anxiety", "name": "Generalized anxiety disorder (GAD)", "category": "chronic", "sources": "Escitalopram 10 mg film-coated tablets SmPC section 4.2 Posology and method of administration (eMC product 7069) · LUSTRAL ® 50 mg film coated tablets SmPC section 4.2 Posology and method of administration (eMC product 1070) · Anxiety - disease-level clinical article (anxiety-full.txt)", "review_status": "reviewed", "verified_against": "Escitalopram 10 mg film-coated tablets SmPC section 4.2 Posology and method of administration (eMC product 7069) · LUSTRAL ® 50 mg film coated tablets SmPC section 4.2 Posology and method of administration (eMC product 1070) · Generalized Anxiety Disorder - disease-level clinical article (anxiety-clinical.txt) · Duloxetine Dr. Reddy's 60 mg Gastro-Resistant Capsules, Hard SmPC (eMC product 6966) · Efexor XL 150 mg hard prolonged release capsules SmPC (eMC product 1219) · Egyptian National Drug Formulary (endf-nervous-2025.txt) · Anxiety - disease-level clinical article (anxiety-full.txt)", "verified_date": "2026-08", "treatments": [ { "id": 205, "generic": "Sertraline", "line": 1, "is_adjunct": false, "form": "oral.solid", "strength_mg": 50.0, "adult_dose": "50 mg once daily, titrate up to max 200 mg daily if required", "adult_duration": "Long-term", "dose_source": "LUSTRAL ® 50 mg film coated tablets SmPC section 4.2 Posology and method of administration (eMC product 1070)", "rationale": "First-choice SSRI per NICE CG113 (most cost-effective); offer first when drug treatment chosen for GAD", "cautions": [ "Do not combine with MAO inhibitors (risk of serotonin syndrome).", "Monitor for worsening anxiety or suicidal ideation during initial 2-4 weeks (especially in patients <25 years).", "Educate patient on 2-4 week lag before full therapeutic response.", "Avoid abrupt cessation (taper over several weeks).", "Monitor for hyponatremia, especially in the elderly.", "NICE CG113 1.2.23 (2011, amended 2020): at the time of publication (Jan 2011) sertraline did not have UK marketing authorisation for GAD, and this is an off-label use for some SSRIs." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Specialist child psychiatry referral required", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "OPIRALINE 50 MG 20 F.C. TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EL-OBOUR", "price_egp": 29.0, "pack_count": 20, "unit_price": 1.45, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "AGRELOCIT 50 MG 20 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MEMPHIS > ATM PHARMACEUTICAL INDUSTRIES", "price_egp": 34.8, "pack_count": 20, "unit_price": 1.74, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DEPR-STAT 50MG 10 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MEMPHIS", "price_egp": 21.6, "pack_count": 10, "unit_price": 2.16, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "SESERINE 50MG 30 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "ADWIA", "price_egp": 75.0, "pack_count": 30, "unit_price": 2.5, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "SERPASS 50MG 30 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "GLOBAL NAPI PHARMACEUTICALS", "price_egp": 102.0, "pack_count": 30, "unit_price": 3.4, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "SIRTO 50MG 10 F.C. TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "HI-PHARM", "price_egp": 34.0, "pack_count": 10, "unit_price": 3.4, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "MOODAPEX 50 MG 30 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MULTI-APEX", "price_egp": 111.0, "pack_count": 30, "unit_price": 3.7, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "LUSTRAL 50 MG 20 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "VIATRIS", "price_egp": 136.0, "pack_count": 20, "unit_price": 6.8, "strength_mg": 50.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "anxiety" }, { "id": 206, "generic": "Escitalopram", "line": 1, "is_adjunct": false, "form": "oral.solid", "strength_mg": 10.0, "adult_dose": "10 mg once daily, may increase to max 20 mg once daily after 2-4 weeks", "adult_duration": "Long-term (continue 6-12 months)", "dose_source": "Escitalopram 10 mg film-coated tablets SmPC section 4.2 Posology and method of administration (eMC product 7069)", "rationale": "First-line SSRI with high selectivity and rapid onset for GAD", "cautions": [ "QTc prolongation is dose-dependent - the maximum dose is 10 mg daily in patients > 65 years.", "Avoid concurrent use with other QTc-prolonging medications.", "Transient increase in anxiety may occur during first 1-2 weeks of treatment.", "Hyponatraemia, probably due to inappropriate antidiuretic hormone secretion (SIADH), has been reported rarely with the use of SSRIs and generally resolves on discontinuation of therapy.", "A meta analysis of placebo controlled clinical trials of antidepressant drugs in adult patients with psychiatric disorders showed an increased risk of suicidal behaviour with antidepressants compared to placebo in patients less than 25 years old." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Escitalopram should not be used in the treatment of children and adolescents under the age of 18 years.", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "ESCTIKANA 10 MG 14 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "HOCHSTER PHARMACEUTICAL INDUSTRIES", "price_egp": 17.0, "pack_count": 14, "unit_price": 1.21, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CITALOMEP 10 MG 14 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MEPACO", "price_egp": 26.0, "pack_count": 14, "unit_price": 1.86, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "ECANOPRAM 10 MG 14 F.C. TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "FUTURE PHARMACEUTICAL INDUSTRIES (FPI) > EGYPTIAN CANADIAN FOR DRUG", "price_egp": 30.0, "pack_count": 14, "unit_price": 2.14, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "MOODAMASH 10 MG 14 F.C. TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MASH PREMIERE", "price_egp": 63.0, "pack_count": 14, "unit_price": 4.5, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "EXCELSA 10 MG 14 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "PHAROPHARMA", "price_egp": 66.0, "pack_count": 14, "unit_price": 4.71, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "ESCITA 10 MG 14 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "GENESIS PHARMACEUTICALS", "price_egp": 77.0, "pack_count": 14, "unit_price": 5.5, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CIPRAPRO 10 MG 30 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MARCYRL PHARMACEUTICAL INDUSTRIES (MPI) > COPAD PHARMA", "price_egp": 237.0, "pack_count": 30, "unit_price": 7.9, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CIPRALEX 10 MG 28 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "LUNDBECK > MULTIPHARMA", "price_egp": 392.0, "pack_count": 28, "unit_price": 14.0, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "XYGAROT 5MG/5ML SYRUP 100ML", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MULTI-APEX", "price_egp": 21.0, "pack_count": null, "unit_price": null, "strength_mg": 5.0, "exact_strength": false, "exact_form": false, "discontinued": false, "also_contains": null }, { "trade_name": "ESCITALOBORG 5 MG/5ML SYRUP 125 ML", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "BORG", "price_egp": 50.0, "pack_count": null, "unit_price": null, "strength_mg": 5.0, "exact_strength": false, "exact_form": false, "discontinued": false, "also_contains": null } ], "condition_id": "anxiety" }, { "id": 207, "generic": "Referral & safety-netting (no drug therapy)", "line": 1, "is_adjunct": false, "form": null, "strength_mg": null, "adult_dose": null, "adult_duration": null, "dose_source": "Generalized Anxiety Disorder - disease-level clinical article (anxiety-clinical.txt)", "rationale": "Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.", "cautions": [ "RED FLAG - Suicide potential is a recognised complication of GAD and needs attention and monitoring." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": null, "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [], "condition_id": "anxiety" }, { "id": 208, "generic": "Duloxetine", "line": 2, "is_adjunct": false, "form": "oral.solid", "strength_mg": null, "adult_dose": "The recommended starting dose in patients with generalised anxiety disorder is 30 mg once daily with or without food. In patients with insufficient response, the dose should be increased to 60 mg, which is the usual maintenance dose in most patients.", "adult_duration": "After consolidation of the response, it is recommended to continue treatment for several months, in order to avoid relapse.", "dose_source": "Duloxetine Dr. Reddy's 60 mg Gastro-Resistant Capsules, Hard SmPC (eMC product 6966)", "rationale": "First-line SNRI option alongside SSRIs for generalized anxiety disorder.", "cautions": [ "Avoid in severe renal impairment (eGFR < 30 mL/min) or chronic liver disease.", "Monitor blood pressure.", "Avoid in end-stage renal disease (CrCl < 30 mL/min) or severe hepatic impairment.", "Nausea, dry mouth, somnolence, and constipation are common." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "The safety and efficacy of duloxetine for the treatment of generalised anxiety disorder in paediatric patients aged 7-17 years have not been established.", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "DEPRETREVE 20MG 20 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "INTERNATIONAL DRUG INDUSTRIES > ANDALOUS PHARMA", "price_egp": 62.0, "pack_count": 20, "unit_price": 3.1, "strength_mg": 20.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DULOPRESSIVE 20 MG 30 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "GLOBAL NAPI PHARMACEUTICALS > TA PHARMA", "price_egp": 112.0, "pack_count": 30, "unit_price": 3.73, "strength_mg": 20.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DEPRETREVE 30MG 20 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "INTERNATIONAL DRUG INDUSTRIES > ANDALOUS PHARMA", "price_egp": 86.0, "pack_count": 20, "unit_price": 4.3, "strength_mg": 30.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "KARBALTA 30 MG 28 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MASH PREMIERE", "price_egp": 212.0, "pack_count": 28, "unit_price": 7.57, "strength_mg": 30.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "KARBALTA 60 MG 30 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MASH PREMIERE", "price_egp": 249.0, "pack_count": 30, "unit_price": 8.3, "strength_mg": 60.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CYMBALTA 30 MG 28 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "ELI LILLY", "price_egp": 399.0, "pack_count": 28, "unit_price": 14.25, "strength_mg": 30.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DUXNORZET 60 MG 30 DEL. REL. H.G. CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "ZETA PHARMA", "price_egp": 231.0, "pack_count": null, "unit_price": null, "strength_mg": 60.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "WADILOXTIN 60 MG 28 DEL. REL. CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "WADI ELNEEL BENTA", "price_egp": 280.0, "pack_count": null, "unit_price": null, "strength_mg": 60.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "anxiety" }, { "id": 209, "generic": "Venlafaxine", "line": 2, "is_adjunct": false, "form": "oral.solid", "strength_mg": null, "adult_dose": "The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. Patients not responding to the initial 75 mg/day dose may benefit from dose increases up to a maximum dose of 225 mg/day. Dosage increases can be made at intervals of 2 weeks or more.", "adult_duration": "Patients should be treated for a sufficient period of time, usually several months or longer.", "dose_source": "Efexor XL 150 mg hard prolonged release capsules SmPC (eMC product 1219)", "rationale": "First-line SNRI option alongside SSRIs for generalized anxiety disorder.", "cautions": [ "Dose-related rise in blood pressure. Measure blood pressure before starting and after each increase, and think hard before exceeding 150 mg/day in a hypertensive patient.", "Withdrawal reactions are more severe and more common than with the fluoxetine and sertraline already listed - never stop abruptly, and warn the patient before they start.", "More toxic in overdose than an SSRI - weigh this where there is self-harm risk, and limit the quantity dispensed.", "Monitor closely for emergent or worsening suicidal thinking in the first weeks and in anyone under 25." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Venlafaxine is not recommended for use in children and adolescents.", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "VENLATRIN 37.5MG 14 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "PHAROPHARMA", "price_egp": 21.6, "pack_count": 14, "unit_price": 1.54, "strength_mg": 37.5, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VENLAFAXINE 37.5 MG SR 7 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "GLOBAL NAPI PHARMACEUTICALS", "price_egp": 14.0, "pack_count": 7, "unit_price": 2.0, "strength_mg": 37.5, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DELVENA 37.5MG 10 TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "DELTA PHARMA", "price_egp": 20.6, "pack_count": 10, "unit_price": 2.06, "strength_mg": 37.5, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "GLOBEXOR 75MG 14 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "GLOBAL NAPI PHARMACEUTICALS", "price_egp": 48.0, "pack_count": 14, "unit_price": 3.43, "strength_mg": 75.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DELVENA 100MG 10 TAB", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "DELTA PHARMA", "price_egp": 45.0, "pack_count": 10, "unit_price": 4.5, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VEXAMOD 37.5MG 10 S.R. CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "SIGMA", "price_egp": 20.0, "pack_count": null, "unit_price": null, "strength_mg": 37.5, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "EFFEGAD 150 MG 28 E.R. CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EPCI > HIKMA PHARMA", "price_egp": 256.0, "pack_count": null, "unit_price": null, "strength_mg": 150.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VENLLAMASH 150 MG 30 EXT. REL. CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MASH PREMIERE", "price_egp": 273.0, "pack_count": null, "unit_price": null, "strength_mg": 150.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "anxiety" }, { "id": 210, "generic": "Diazepam", "line": 2, "is_adjunct": true, "form": "oral.solid", "strength_mg": null, "adult_dose": "Oral: 2 mg to 10 mg, 2 to 4 times daily, according to severity, up to 30 mg daily in divided doses. The lowest effective dose should be used; duration of use should not exceed 4 weeks.", "adult_duration": "duration of use should not exceed 4 weeks", "dose_source": "Egyptian National Drug Formulary (endf-nervous-2025.txt)", "rationale": "Short-term benzodiazepine anxiolytic for immediate symptom reduction in severe anxiety.", "cautions": [ "There is a high risk of respiratory depression if diazepam is combined with ongoing alcohol ingestion.", "Severe liver failure patients require short-acting benzodiazepines (e.g. oxazepam) to avoid accumulation." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "General dosing: Oral: 1 mg to 2.5 mg, 3 or 4 times daily initially; increase gradually as needed and tolerated. Not recommended for use in pediatric patients under 6 months.", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": [ { "label": "6 months and over", "age_min_months": 6, "age_max_months": 216, "dose_text": "By mouth: 1 mg to 2.5 mg, 3 or 4 times daily to start, increased gradually as needed and tolerated. Not recommended under 6 months." } ], "peds_doses": null, "brands": [ { "trade_name": "FARCOZEPAM 5MG 20 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "PHARCO", "price_egp": 4.5, "pack_count": 20, "unit_price": 0.23, "strength_mg": 5.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VALPAM 2MG 10 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "AMOUN", "price_egp": 2.75, "pack_count": 10, "unit_price": 0.28, "strength_mg": 2.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VALPAM 5MG 10 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "AMOUN", "price_egp": 3.0, "pack_count": 10, "unit_price": 0.3, "strength_mg": 5.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "EPIVAL 10 MG 20 TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EIPICO", "price_egp": 11.0, "pack_count": 20, "unit_price": 0.55, "strength_mg": 10.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "NEURIL 2MG 10 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MEMPHIS", "price_egp": 5.75, "pack_count": 10, "unit_price": 0.57, "strength_mg": 2.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "NEURIL 5MG 20TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MEMPHIS", "price_egp": 15.0, "pack_count": 20, "unit_price": 0.75, "strength_mg": 5.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VALINIL 5MG 30TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EL NILE.", "price_egp": 22.5, "pack_count": 30, "unit_price": 0.75, "strength_mg": 5.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VALPAM 2MG/5ML SYRUP 120ML", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "AMOUN", "price_egp": 5.95, "pack_count": null, "unit_price": null, "strength_mg": 2.0, "exact_strength": false, "exact_form": false, "discontinued": false, "also_contains": null } ], "condition_id": "anxiety" } ] }